ARLG at IDWeek 2025

Posted on by AM

IDWeek 2025 is here! Whether you’re attending in person in Atlanta, GA or online, you can hear some of ARLG’s top leaders and experts discuss the latest AMR topics.

You won’t want to miss this year’s SHEA Lectureship, which was awarded to ARLG’s Mentoring Committee Chair, Anthony Harris, MD, MPH. This award recognizes his important contributions to the fields of health care epidemiology, infection prevention, and antimicrobial stewardship through his leadership and mentorship. Dr. Harris will give his lecture, “Where is the true north of infection control?” on Tuesday, October 21 at 4:45 p.m. ET.

Check out the ARLG member sessions and presentations in the tables below, or view the full schedule and on-demand content at IDWeek.org.

Sessions

DayTime (ET)Session TitlePresentation TitleModeratorsSpeakers
10/19/202510:45 - 11:30 amPW07 – Expanding Your Influence to Improve Antibiotic Use in Outpatient Settings Advancing Outpatient Stewardship in Health SystemsRitu Banerjee
10/19/202510:50 am - 12:15 pmPW04 – Fellows’ Day WorkshopCareers in ResearchCesar Arias
10/19/20252:40 – 3:15 pm2 – Beyond the 101: Pondering Perplexing Prescribing IssuesCan We Use Ceftriaxone Susceptibility to Interpret Susceptibility to Third-Generation Cephalosporins?Pranita Tamma
10/19/20253:45 – 5:30 pm8 – Opening Plenary: Reflection and Renewal: Advancing Public Health in Challenging TimesYohei Doi
10/20/20258:00 – 9:00 am15 – New Antimicrobials in the PipelineDavid van Duin
10/20/20258:00 – 8:30 am17 – These Blind Mice: When Bench Doesn’t Meet Bedside Optimizing Dosing Strategies: Insights From Systems Pharmacology and Experimental ModelsGauri Rao
10/20/20258:00 – 9:00 am18 – Top 10 Papers in Antimicrobial ResistanceYohei Doi
10/20/202510:55 - 11:20 am24 – Applying Next-Generation Sequencing to Clinical Treatment and PreventionCases in Genotype-Phenotype in the Microbiology Laboratory: What Clinician Need to KnowAmy Mathers
10/20/202510:30 - 11:45 am25 – Blood and Guts: Microbiome DiscoveriesDavid van Duin
10/20/202510:30 - 11:45 am30 – Lessons Learned in Biopreparedness and Biocontainment: Lassa Fever in the MidwestYohei Doi
10/20/20252:21 – 2:39 pm64 – Out With the Old, in With the New: Time to Update the Management of Staphylococcus aureus infectionsShould Ceftobiprole Replace Ceftaroline in the Management of Persistent Staphylococcal Bacteremia?Nicholas Turner
10/20/20251:45 – 3:00 pm 72 – Late Breaking Trial Results for Viral and Bacterial InfectionsYohei Doi
10/20/20253:15 – 4:30 pm 84 – Diagnostic Clinical Cases: What Do I Do With This Test Result?Ritu Banerjee
10/20/20253:15-4:30 pm87 – Extra, Extra New Info on Treating and Preventing RSV and InfluenzaAngelique Boutzoukas
10/20/20253:15-4:30 pm88 – New Anti-Infective AgentsPranita Tamma
10/20/20253:15-4:30 pm84 – Commonalities and Differences in Antimicrobial Treatment of Resistant PathogensYohei Doi
10/21/20258:00 – 9:00 am99 – Diagnostic Trials: Past and FutureRobin Patel, Ritu Banerjee
10/21/20258:00 – 8:30 am99 – Diagnostic Trials: Past and FutureEvaluation of Infectious Disease Diagnostics: Innovative Study Designs to Assess Test PerformanceMichael Satlin
10/21/20258:30 – 9:00 am99 – Diagnostic Trials: Past and FutureEvaluation of Infectious Disease Diagnostics: Study Designs to Assess Impact on Clinical OutcomesSarah Doernberg
10/21/20258:00 – 9:00 am104 – Pediatric Antimicrobial Resistance: Key Updates for the Busy ClinicianLatania Logan, Pranita Tamma
10/21/20258:30 – 9:00 am104 – Pediatric Antimicrobial Resistance: Key Updates for the Busy ClinicianUpdates in Gram-Negative BacteriaAngelique Boutzoukas
10/21/20259:15 -10:00 am107 – Maxwell Finland LectureYohei Doi
10/21/20259:35 -10:00 am107 – Maxwell Finland LectureAntimicrobial Resistance at the Bedside: Translating Science into Patient OutcomesCesar Arias
10/21/20251:45 – 3:00 pm157 – Cavities, Appys, and CLABSis, Oh My! Perspectives From Our Surgery and Radiology ColleaguesLatania Logan
10/21/20251:45 – 3:00 pm162 – Fresh New Results On Old and New VaccinesAhmed Babiker
10/21/20251:45 – 3:00 pm163 – Lowering Barriers to Diagnostics Access to Reduce Health Inequalities and Improve OutcomesRitu Banerjee
10/21/20253:15 – 4:30 pm171 – New Antibiotics, Untapped Potential: Exploring the Underuse of Recently Approved AgentsThomas Lodise
10/21/20254:05 – 4:30 pm172 – Bug to Drug: Translating Mechanisms of Antimicrobial Resistance to Treatment of Challenging InfectionsTranslational Antimicrobial Resistance Research in Low-Resource SettingsJose Munita
10/21/20253:15 – 4:30 pm173 – Challenging Cases in Immunocompromised HostMichael Satlin (panelist)
10/21/20255:25 – 5:55 pm183 – SHEA LectureshipWhere is the True North of Infection Control?Anthony Harris
10/21/20254:45 – 6:00 pm184 – Stanley A. Plotkin Lecture in VaccinologyLatania Logan
10/22/20258:00 –8:20 am191 – One Size Fits One: Toward Individualized Management of Infectious DiseasesMolecular Diagnostics to Refine Duration of Therapy for Blood Stream Infection: S. aureusVance Fowler
10/22/202510:30 -10:55 am197 – Clinical Trials That Will Change Your PracticeTrials in Bacteriology That May Change Your PracticeAmy Mathers
10/22/20251:45-3:00 pm241 – Advances in Managing Antimicrobial ToxicitiesAmit Pai
10/22/20253:15 – 4:30 pm257 – Cracking the Code of Resistance: A Deep Dive Into Metallo-Beta-Lactamase From Bench to BedsideYohei Doi, Amy Mathers
10/22/20253:15 – 3:40 pm257 – Cracking the Code of Resistance: A Deep Dive Into Metallo-Beta-Lactamase From Bench to BedsideUnmasking Resistance: Epidemiology and Diversity of MBLsMaria Mojica
10/22/20253:15 – 4:30 pm259 – Driving Better Decisions: Incentivizing Diagnostic StewardshipRitu Banerjee
10/22/20253:15 – 4:30 pm266 – Why Do We Do This? Exploring the Data Behind Long-Established Practices in IDDouble Coverage; Do We Need It?Kerry LaPlante

Posters & Oral Presentations

DayTime (ET)TitlePresenting AuthorAuthors
10/20/202511:18 – 11:30 am78 – Oral Presentation: Aerobactin Gene iuc as a Virulence Marker Associated with Increased Mortality in Carbapenem-Resistant Klebsiella pneumoniae infections: A Multicenter Observational Cohort Study from ChinaJianping JiangJiang JJ, Li Y, Komarow L, Boutzoukas A, Yu Y, Xiao Y, Gao H, Liu Z, Fowler Jr VG, Kreiswirth BN, Chen L, Wang M, van Duin D, for the Antibacterial Resistance Leadership Group
10/20/202512:15-1:30 pmP-476 – Poster Presentation: Risk Factors for Mortality in Children and Young Adults with Carbapenem-Resistant Gram-Negative InfectionsAngelique BoutzoukasBoutzoukas AE, Tian J, Komarow L, Ge L, Wang M, Arias C, Guttierrez JMO, Alenazi T, Liu Z, Paterson D, Satlin M, Doi Y, Fowler V, van Duin D
10/21/202512:15 – 1:30 pmP-1292 – Poster Presentation: Clinical and Genomic Features of Colistin Resistance Among Carbapenem-resistant Acinetobacter baumannii Isolated From Global Clinical SamplesMadison StellfoxStellfox ME, Komarow L, Patel R, van Duin D, Van Tyne D, Doi Y
10/21/202512:15 – 1:30 pmP-1296 – Poster Presentation:
Impact of Metallo-Beta Lactamases on Outcomes in Patients with Carbapenem-Resistant Gram-Negative Infections		Angelique BoutzoukasBoutzoukas AE, Shao W, Jiang J, Kanj S, Wang M, Salcedo Mendoza S, Marimuthu K, Liu Z, Komarow L, Fowler V, Kreiswirth B, Arias C, Doi Y, Paterson D, Satlin M, Bonomo R, van Duin D
10/21/202512:15 – 1:30 pmP-1302 – Poster Presentation:
Klebsiella pneumoniae Phage Susceptibility Testing (PST): Comparison Between a Spot Plaque Assay and an Optical Density-Based Liquid Assay		Luz CuelloCuello L, Patel R
10/22/202510:45 – 11:00 am556 – Oral Presentation:
Using a novel Anaerobic Activity Index to assess risk for poor outcomes in burn patients in a burn intensive care unit		Natalie MackowMackow NA, Komarow L, Napravnik S, Bartelt L, DiBiase LM, Williams B, Williams FN, Weber DJ, van Duin D